Xiaoyan Han Selected Research

Xiaoyan Han Research Topics

Disease

17	Neoplasms (Cancer) 04/2024 - 01/2017
15	Multiple Myeloma 05/2024 - 01/2014
10	Infections 10/2023 - 10/2005
9	Cataract (Cataracts) 12/2022 - 01/2020
6	Asthma (Bronchial Asthma) 01/2023 - 12/2016
4	Inflammation (Inflammations) 03/2024 - 03/2020
4	Sepsis (Septicemia) 01/2018 - 10/2015
3	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2017
3	Disease Progression 01/2023 - 11/2010
3	Myopia 01/2023 - 01/2020
3	Wounds and Injuries (Trauma) 05/2021 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2017
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018 - 05/2016
3	Bacterial Infections (Bacterial Infection) 06/2017 - 10/2015
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 04/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 12/2020
2	Carcinoma (Carcinomatosis) 01/2024 - 10/2017
2	Ischemic Stroke 12/2023 - 01/2022
2	Herpes Zoster 01/2022 - 01/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2017
2	Hemorrhage 04/2021 - 10/2008
2	Colonic Neoplasms (Colon Cancer) 04/2021 - 01/2016
2	Leukemia 01/2021 - 01/2018
2	Acute Promyelocytic Leukemia 01/2021 - 02/2018
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2019
2	Hypertension (High Blood Pressure) 01/2021 - 01/2020
2	AIDS-Related Complex (ARC) 01/2021 - 01/2021
2	Erectile Dysfunction 01/2020 - 01/2019
2	Critical Illness (Critically Ill) 01/2018 - 06/2017
2	Breast Neoplasms (Breast Cancer) 01/2017 - 06/2009
2	Foot Rot 05/2008 - 07/2007
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2024
1	Ischemia 02/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Stroke (Strokes) 12/2023
1	Thrombosis (Thrombus) 12/2023

Drug/Important Bio-Agent (IBA)

7	Bortezomib (Velcade)FDA Link 01/2022 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2015
5	Prednisone (Sone)FDA LinkGeneric 01/2023 - 01/2017
4	C-Reactive ProteinIBA 01/2022 - 05/2016
3	daratumumabIBA 05/2024 - 01/2023
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2019
3	LipidsIBA 01/2022 - 01/2021
3	Fibrinogen (Factor I)FDA Link 01/2021 - 05/2016
3	CholesterolIBA 01/2021 - 01/2019
3	Proteasome InhibitorsIBA 01/2021 - 01/2018
3	ProcalcitoninIBA 01/2018 - 05/2016
3	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2015
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2018 - 05/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2017 - 05/2015
2	Transfer RNA (tRNA)IBA 01/2023 - 01/2020
2	AlbuminsIBA 01/2023 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 11/2022 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 11/2022 - 01/2022
2	Air Pollutants (Pollutants, Air)IBA 08/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2020
2	SteroidsIBA 01/2022 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
2	Acyclovir (Aciclovir)FDA LinkGeneric 01/2022 - 01/2014
2	LDL CholesterolIBA 01/2021 - 01/2019
2	EphA1 Receptor (Eph Receptor)IBA 01/2021 - 01/2021
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 11/2018
2	oxidized low density lipoproteinIBA 01/2021 - 01/2019
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2021
2	HDL CholesterolIBA 01/2021 - 01/2019
2	EphrinsIBA 01/2021 - 01/2021
2	AntibodiesIBA 12/2020 - 01/2017
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 08/2020 - 10/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2020 - 10/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 10/2017
2	vernodalolIBA 02/2018 - 10/2017
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 05/2016
2	Ferritins (Ferritin)IBA 01/2018 - 05/2016
2	HaptoglobinsIBA 01/2018 - 05/2016
2	Clindamycin (Cleocin)FDA LinkGeneric 07/2015 - 05/2015
1	pomalidomideIBA 05/2024
1	ConnexinsIBA 04/2024
1	DNA (Deoxyribonucleic Acid)IBA 02/2024
1	Artificial Membranes (Artificial Membrane)IBA 02/2024
1	Neuroprotective AgentsIBA 02/2024
1	ReninIBA 01/2024
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2023
1	GinkgolidesIBA 12/2023
1	DiterpenesIBA 12/2023
1	platelet activating factor receptorIBA 12/2023
1	Meglumine FDA Link 12/2023
1	Platelet Activating FactorIBA 12/2023

Therapy/Procedure

15	Therapeutics 05/2024 - 01/2014
7	Drug Therapy (Chemotherapy) 02/2024 - 02/2015
3	Immunotherapy 02/2024 - 01/2022
3	Hematopoietic Stem Cell Transplantation 01/2019 - 10/2011
2	Radiotherapy 06/2023 - 04/2021
2	Vitrectomy 12/2022 - 01/2020
2	Intraocular Lenses (Intraocular Lens) 05/2021 - 01/2021
2	Transplantation 01/2019 - 04/2011
2	Ambulatory Care (Outpatient Care) 10/2016 - 12/2005
1	Chemoradiotherapy 04/2024
1	Immunomodulation 03/2024